Inhibikase Grants Stock Options to New Employees Under Inducement Plan
WILMINGTON, DE — Inhibikase Therapeutics Inc. (Nasdaq: IKT) recently granted stock options covering 685,718 shares to five newly hired non-executive employees under its 2026 Inducement Equity Plan, the company announced.
Inhibikase Grants Stock Options to New Employees Under Inducement Plan Read More